US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

15.16

+0.08000.53%

Volume:17.39K

Turnover:262.37K

Market Cap:2.64B

PE:5.72

High:15.24

Open:15.16

Low:14.69

Close:15.08

52wk High:19.50

52wk Low:11.51

Shares:174.43M

Float Shares:104.00M

Volume Ratio:0.86

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.65

EPS(LYR):0.2000

ROE:46.90%

ROA:-0.81%

PB:2.15

PE(LYR):75.80

Loading ...

Overview Company News Filings

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Multiple Positive Catalysts Drive Five-Day Rally, Is HUTCHMED (00013) Turning Around After Missing the Bull Run?

Hutchmed Says Autoimmune Disorder Trial in China Meets Primary Endpoint

MT Newswires Live

HUTCHMED (00013) Announces Positive Top-Line Results from Phase III Stage of ESLIM-02 Study of Sovleplenib in Warm Antibody Autoimmune Hemolytic Anemia in China

A Look At Edgewise Therapeutics (EWTX) Valuation After Positive CIRRUS HCM Phase 2 Trial Update

Simply Wall St.

Malaysian Shares Rebound Mirroring Regional Gains; Vetece's Shares Rise 4%

MT Newswires Live

Hutchmed Starts Phase III Trial of Pancreatic Cancer Treatment Combination

MT Newswires Live

Vetece Unit Wins About MYR13 Million HCM Cloud Deal

MT Newswires Live

HUTCHMED (00013) Initiates Phase III Stage of Ongoing Study of Surufatinib Combined with Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

Hutchmed Says New Application for Gastric Cancer Treatment Gets Priority Review in China

MT Newswires Live

HUTCHMED (00013) Announces NDA Acceptance and Priority Review Status in China for Savolitinib in MET-Amplified Gastric Cancer

Hutchmed Says Chinese Regulator Granted Priority Review Status to New Drug Application for Fanregratinib

MT Newswires Live

HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy

Hutchmed Begins Phase 1 Study of HMPL-A251 Monotherapy to Treat Patients With Solid Tumors

MT Newswires Live

HUTCHMED (00013) Initiates Global Clinical Development of ATTC Candidate HMPL-A251 for Solid Tumors

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Press Release: UKG Agrees to Acquire Inova Payroll

Tenaya Therapeutics Announces Proposed Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HCM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HCM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCM\",,,,,undefined,":{"symbol":"HCM","market":"US","secType":"STK","nameCN":"Hutchison China Meditech","latestPrice":15.16,"timestamp":1772053200000,"preClose":15.08,"halted":0,"volume":17393,"delay":0,"changeRate":0.005305039787798413,"floatShares":104000000,"shares":174433934,"eps":2.649215,"marketStatus":"Pre-Mkt","change":0.08,"latestTime":"02-26 07:59:23 EST","open":15.1643,"high":15.24,"low":14.69,"amount":262366.7913,"amplitude":0.036472,"askPrice":16.17,"askSize":100,"bidPrice":12.84,"bidSize":100,"shortable":3,"etf":0,"ttmEps":2.649215,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":1,"adrRate":5,"listingDate":1458187200000,"exchange":"NASDAQ","adjPreClose":15.16,"postHourTrading":{"tag":"盘后","latestPrice":15.16,"preClose":15.16,"latestTime":"19:57 EST","volume":42,"amount":630.92,"timestamp":1772067441532,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8596798006233451,"impliedVol":0.1941,"impliedVolPercentile":0.276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCM\",,,,,undefined,":{"symbol":"HCM","floatShares":104000000,"roa":"-0.81%","roe":"46.90%","lyrEps":0.199995,"volumeRatio":0.8596798006233451,"shares":174433934,"dividePrice":0,"high":15.24,"amplitude":0.036472,"preClose":15.08,"low":14.69,"week52Low":11.505,"pbRate":"2.15","psRate":"4.39","week52High":19.5,"institutionHeld":0,"latestPrice":15.16,"eps":2.649215,"divideRate":0,"volume":17393,"delay":0,"ttmEps":2.649215,"open":15.1643,"prevYearClose":13.33,"prevWeekClose":15.29,"prevMonthClose":15,"prevQuarterClose":13.33,"fiveDayClose":15.1,"twentyDayClose":15.24,"sixtyDayClose":14.32,"earningDate":1772640000000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HCM\",params:#limit:5,,,undefined,":[{"date":"2026-03-05","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1772701200000,"name":null,"time":"Pre-Market","dateTimestamp":1772686800000,"actualEps":null},{"market":"US","date":"2025-08-07","symbol":"HCM","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-03-19","symbol":"HCM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"date":"2024-07-31","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":null,"defaultRemindTime":1722412800000,"name":null,"time":"Pre-Market","dateTimestamp":1722398400000,"actualEps":null},{"date":"2024-02-28","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1709110800000,"name":null,"time":"Pre-Market","dateTimestamp":1709096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HCM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HCM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.1667,"sell":0.0833,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1758776400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HCM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HCM","date":"2026-02-25","current":5.72245,"percent":0.783673,"low":-115.327022,"twenty":-64.328552,"median":-12.132965,"eighty":5.577919,"high":86.489551,"avg":-20.793661,"sd":44.005049,"marketCap":2559888113.93},"quantilePoints":[{"date":"2021-02-26","current":-38.841579,"twenty":-89.766106,"median":-41.816439,"eighty":-27.778854,"marketCap":4286129378.92},{"date":"2021-03-05","current":-33.870975,"twenty":-89.003074,"median":-41.41365,"eighty":-27.776445,"marketCap":4258597777.62},{"date":"2021-03-12","current":-32.350855,"twenty":-88.635912,"median":-41.151481,"eighty":-27.776445,"marketCap":4067472920.26},{"date":"2021-03-19","current":-33.249369,"twenty":-87.307229,"median":-40.874511,"eighty":-27.776445,"marketCap":4180443207.02},{"date":"2021-03-26","current":-30.982552,"twenty":-86.768103,"median":-40.703264,"eighty":-27.778854,"marketCap":3895436248.03},{"date":"2021-04-01","current":-32.26063,"twenty":-86.192609,"median":-40.508564,"eighty":-27.778854,"marketCap":4056129016.55},{"date":"2021-04-09","current":-33.137949,"twenty":-84.984122,"median":-40.185037,"eighty":-27.776445,"marketCap":4166434318.18},{"date":"2021-04-16","current":-34.129797,"twenty":-84.235269,"median":-40.070583,"eighty":-27.776445,"marketCap":4291139241.78},{"date":"2021-04-23","current":-34.843079,"twenty":-84.024169,"median":-40.002655,"eighty":-27.776445,"marketCap":4380820320.94},{"date":"2021-04-30","current":-34.438006,"twenty":-83.830644,"median":-39.797322,"eighty":-27.776445,"marketCap":4329890574.8},{"date":"2021-05-07","current":-31.821317,"twenty":-83.830644,"median":-39.648909,"eighty":-27.776445,"marketCap":4000894157.31},{"date":"2021-05-14","current":-30.312709,"twenty":-83.490922,"median":-39.473341,"eighty":-27.776445,"marketCap":3811216913.73},{"date":"2021-05-21","current":-32.458918,"twenty":-83.490922,"median":-39.204978,"eighty":-27.776445,"marketCap":4081059812.14},{"date":"2021-05-28","current":-34.354172,"twenty":-83.387891,"median":-38.87818,"eighty":-27.776445,"marketCap":4319349995.04},{"date":"2021-06-04","current":-35.068157,"twenty":-82.646756,"median":-38.63441,"eighty":-27.776445,"marketCap":4409119282.86},{"date":"2021-06-11","current":-35.414599,"twenty":-81.346061,"median":-38.54063,"eighty":-27.776445,"marketCap":4452677569.33},{"date":"2021-06-18","current":-34.032624,"twenty":-77.803409,"median":-38.350657,"eighty":-27.776445,"marketCap":4278921905.79},{"date":"2021-06-25","current":-35.828259,"twenty":-76.471988,"median":-38.192608,"eighty":-27.732156,"marketCap":5400465105.51},{"date":"2021-07-02","current":-43.838432,"twenty":-74.83281,"median":-38.175147,"eighty":-27.732156,"marketCap":6607854466.82},{"date":"2021-07-09","current":-41.097094,"twenty":-74.120934,"median":-38.175147,"eighty":-27.732156,"marketCap":6194647318.34},{"date":"2021-07-16","current":-44.549309,"twenty":-72.365744,"median":-38.175147,"eighty":-27.732156,"marketCap":6715006390.46},{"date":"2021-07-23","current":-45.310589,"twenty":-70.91277,"median":-38.175147,"eighty":-27.732156,"marketCap":6829755650.02},{"date":"2021-07-30","current":-39.696122,"twenty":-69.643297,"median":-38.175147,"eighty":-27.732156,"marketCap":7083098072.62},{"date":"2021-08-06","current":-40.119386,"twenty":-69.529012,"median":-38.24796,"eighty":-27.870771,"marketCap":7158622428.55},{"date":"2021-08-13","current":-39.097534,"twenty":-69.529012,"median":-38.459009,"eighty":-28.149056,"marketCap":6976290399.57},{"date":"2021-08-20","current":-36.065012,"twenty":-69.529012,"median":-38.476067,"eighty":-28.245756,"marketCap":6435188201.17},{"date":"2021-08-27","current":-35.744125,"twenty":-69.529012,"median":-38.476067,"eighty":-28.472218,"marketCap":6377931431.79},{"date":"2021-09-03","current":-40.719987,"twenty":-69.529012,"median":-38.500254,"eighty":-28.576552,"marketCap":7265789374.3},{"date":"2021-09-10","current":-37.614485,"twenty":-69.529012,"median":-38.500254,"eighty":-28.654578,"marketCap":6711665355.27},{"date":"2021-09-17","current":-36.698865,"twenty":-69.529012,"median":-38.500254,"eighty":-28.733157,"marketCap":6548288680.59},{"date":"2021-09-24","current":-35.293788,"twenty":-69.529012,"median":-38.500254,"eighty":-29.073592,"marketCap":6297576451.05},{"date":"2021-10-01","current":-34.394618,"twenty":-69.529012,"median":-38.500254,"eighty":-29.166917,"marketCap":6137134715.17},{"date":"2021-10-08","current":-32.006355,"twenty":-69.529012,"median":-38.500254,"eighty":-29.281853,"marketCap":5710989951.59},{"date":"2021-10-15","current":-30.941818,"twenty":-69.529012,"median":-38.500254,"eighty":-29.322519,"marketCap":5521041305.66},{"date":"2021-10-22","current":-31.083316,"twenty":-69.529012,"median":-38.500254,"eighty":-29.56411,"marketCap":5546289439.2},{"date":"2021-10-29","current":-28.737101,"twenty":-69.529012,"median":-38.500254,"eighty":-29.623518,"marketCap":5127647054.8},{"date":"2021-11-05","current":-29.069569,"twenty":-69.529012,"median":-38.500254,"eighty":-29.71681,"marketCap":5186970395.65},{"date":"2021-11-12","current":-29.581373,"twenty":-69.529012,"median":-38.500254,"eighty":-29.71681,"marketCap":5278293116.21},{"date":"2021-11-19","current":-29.210209,"twenty":-69.529012,"median":-38.500254,"eighty":-29.770213,"marketCap":5212065210.66},{"date":"2021-11-26","current":-34.003345,"twenty":-69.529012,"median":-38.500254,"eighty":-29.883033,"marketCap":6067318798.77},{"date":"2021-12-03","current":-32.23822,"twenty":-69.529012,"median":-38.500254,"eighty":-29.920748,"marketCap":5752362415.71},{"date":"2021-12-10","current":-32.455639,"twenty":-69.529012,"median":-38.500254,"eighty":-29.981314,"marketCap":5791157109.58},{"date":"2021-12-17","current":-33.631509,"twenty":-69.529012,"median":-38.500254,"eighty":-30.078029,"marketCap":6000971032.9},{"date":"2021-12-23","current":-34.093269,"twenty":-69.529012,"median":-38.500254,"eighty":-30.131346,"marketCap":6083364180.02},{"date":"2021-12-31","current":-34.446938,"twenty":-69.529012,"median":-38.500254,"eighty":-30.191644,"marketCap":6146470612.85},{"date":"2022-01-07","current":-32.437839,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":5787980958.33},{"date":"2022-01-14","current":-30.159284,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":5381411525.89},{"date":"2022-01-21","current":-28.701706,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":5121331366.35},{"date":"2022-01-28","current":-25.003785,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4461500388},{"date":"2022-02-04","current":-26.206511,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4676106460.92},{"date":"2022-02-11","current":-25.261882,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4507553408.67},{"date":"2022-02-18","current":-25.371388,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4527092765.71},{"date":"2022-02-25","current":-25.683001,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4582694996.65},{"date":"2022-03-04","current":-18.605078,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3621441412.39},{"date":"2022-03-11","current":-15.051903,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":2929822790.96},{"date":"2022-03-18","current":-17.884701,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3481221099.72},{"date":"2022-03-25","current":-16.435173,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3199073429.96},{"date":"2022-04-01","current":-17.213787,"twenty":-69.499738,"median":-38.495738,"eighty":-30.296587,"marketCap":3350629340.45},{"date":"2022-04-08","current":-16.063966,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":3126818936.54},{"date":"2022-04-14","current":-15.298862,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":2977892925.34},{"date":"2022-04-22","current":-14.712002,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":2863661789.31},{"date":"2022-04-29","current":-13.558507,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":2639136325.07},{"date":"2022-05-06","current":-9.781934,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":1904033919.87},{"date":"2022-05-13","current":-9.355898,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":1821106717.16},{"date":"2022-05-20","current":-8.719868,"twenty":-69.499738,"median":-38.495738,"eighty":-30.192872,"marketCap":1697304784.04},{"date":"2022-05-27","current":-8.314191,"twenty":-69.499738,"median":-38.495738,"eighty":-30.132008,"marketCap":1618340539.42},{"date":"2022-06-03","current":-8.628685,"twenty":-69.499738,"median":-38.495738,"eighty":-30.014085,"marketCap":1679556410.8},{"date":"2022-06-10","current":-9.214019,"twenty":-69.499738,"median":-38.495738,"eighty":-29.921757,"marketCap":1793490418.23},{"date":"2022-06-17","current":-9.914833,"twenty":-69.499738,"median":-38.495738,"eighty":-29.772739,"marketCap":1929902622.2},{"date":"2022-06-24","current":-11.463874,"twenty":-69.529012,"median":-38.500254,"eighty":-29.620948,"marketCap":2231420118.48},{"date":"2022-07-01","current":-11.684606,"twenty":-69.529012,"median":-38.500254,"eighty":-29.322519,"marketCap":2274385364.21},{"date":"2022-07-08","current":-13.343207,"twenty":-69.529012,"median":-38.500254,"eighty":-29.287087,"marketCap":2597228702.6},{"date":"2022-07-15","current":-11.176596,"twenty":-69.529012,"median":-38.500254,"eighty":-29.224911,"marketCap":2175501973.98},{"date":"2022-07-22","current":-11.270185,"twenty":-69.529012,"median":-38.500254,"eighty":-29.070663,"marketCap":2193719071.38},{"date":"2022-07-29","current":-11.175537,"twenty":-69.529012,"median":-38.500254,"eighty":-28.942893,"marketCap":2175295964.08},{"date":"2022-08-05","current":-8.775775,"twenty":-69.251314,"median":-38.382485,"eighty":-28.654578,"marketCap":2238805741.78},{"date":"2022-08-12","current":-9.033436,"twenty":-68.891568,"median":-38.244645,"eighty":-28.437317,"marketCap":2304538127.97},{"date":"2022-08-19","current":-8.567373,"twenty":-68.544113,"median":-38.122097,"eighty":-28.189312,"marketCap":2185639465.6},{"date":"2022-08-26","current":-8.387311,"twenty":-68.170644,"median":-38.040806,"eighty":-28.005292,"marketCap":2139703595.07},{"date":"2022-09-02","current":-8.548157,"twenty":-67.834739,"median":-37.799605,"eighty":-27.755834,"marketCap":2180737445.02},{"date":"2022-09-09","current":-9.050042,"twenty":-67.711165,"median":-37.635536,"eighty":-27.581671,"marketCap":2308774223.62},{"date":"2022-09-16","current":-7.943729,"twenty":-67.568141,"median":-37.567583,"eighty":-27.025151,"marketCap":2026540548.26},{"date":"2022-09-23","current":-5.590294,"twenty":-67.181713,"median":-37.492528,"eighty":-26.772818,"marketCap":1426151024.94},{"date":"2022-09-30","current":-6.0166,"twenty":-66.839726,"median":-37.322153,"eighty":-26.671597,"marketCap":1534906655.67},{"date":"2022-10-07","current":-5.591973,"twenty":-66.311726,"median":-37.125983,"eighty":-26.346066,"marketCap":1426579346.77},{"date":"2022-10-14","current":-5.380359,"twenty":-65.731379,"median":-36.974767,"eighty":-26.200139,"marketCap":1372594209.76},{"date":"2022-10-21","current":-5.717908,"twenty":-65.287627,"median":-36.817162,"eighty":-25.987978,"marketCap":1458706953.83},{"date":"2022-10-28","current":-5.527847,"twenty":-64.824798,"median":-36.677678,"eighty":-25.683533,"marketCap":1410220116.58},{"date":"2022-11-04","current":-5.851883,"twenty":-64.330928,"median":-36.605148,"eighty":-25.425489,"marketCap":1492885555.67},{"date":"2022-11-11","current":-6.401199,"twenty":-64.014025,"median":-36.490673,"eighty":-25.004374,"marketCap":1633022846.35},{"date":"2022-11-18","current":-7.274108,"twenty":-63.706519,"median":-36.322732,"eighty":-24.409241,"marketCap":1855712187.21},{"date":"2022-11-25","current":-7.207228,"twenty":-63.464069,"median":-36.186955,"eighty":-24.11915,"marketCap":1838650480.47},{"date":"2022-12-02","current":-9.190517,"twenty":-63.185779,"median":-36.105478,"eighty":-23.638994,"marketCap":2344610998.55},{"date":"2022-12-09","current":-9.61663,"twenty":-63.052013,"median":-35.941799,"eighty":-23.186635,"marketCap":2453317745.69},{"date":"2022-12-16","current":-9.580976,"twenty":-62.885553,"median":-35.895711,"eighty":-22.098398,"marketCap":2444222152.95},{"date":"2022-12-23","current":-9.787361,"twenty":-62.624453,"median":-35.77363,"eighty":-19.25547,"marketCap":2496873279.39},{"date":"2022-12-30","current":-10.536978,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2688109439.12},{"date":"2023-01-06","current":-11.292055,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2880738826.05},{"date":"2023-01-13","current":-12.006871,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3063096916},{"date":"2023-01-20","current":-11.709152,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2987145347.84},{"date":"2023-01-27","current":-13.678274,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3489492038.73},{"date":"2023-02-03","current":-13.421402,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3423960784.69},{"date":"2023-02-10","current":-11.253893,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2871003089.59},{"date":"2023-02-17","current":-11.126783,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2838575719.48},{"date":"2023-02-24","current":-10.526624,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2685468087.11},{"date":"2023-03-03","current":-8.178091,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2950941580.83},{"date":"2023-03-10","current":-7.048231,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2543248476.73},{"date":"2023-03-17","current":-6.898847,"twenty":-62.129617,"median":-35.521426,"eighty":-17.494664,"marketCap":2489345563.09},{"date":"2023-03-24","current":-6.686154,"twenty":-61.887252,"median":-35.353445,"eighty":-16.993619,"marketCap":2412598207.8},{"date":"2023-03-31","current":-6.37509,"twenty":-61.656831,"median":-35.262393,"eighty":-16.360932,"marketCap":2300355689.58},{"date":"2023-04-06","current":-6.683867,"twenty":-61.173417,"median":-35.179989,"eighty":-15.530351,"marketCap":2411773158.27},{"date":"2023-04-14","current":-8.330975,"twenty":-60.579404,"median":-34.997612,"eighty":-15.233985,"marketCap":3006107420.26},{"date":"2023-04-21","current":-7.844979,"twenty":-58.935582,"median":-34.87491,"eighty":-14.298511,"marketCap":2830742978.45},{"date":"2023-04-28","current":-7.371003,"twenty":-58.19167,"median":-34.698276,"eighty":-13.498182,"marketCap":2659716150.51},{"date":"2023-05-05","current":-7.738249,"twenty":-57.886927,"median":-34.494942,"eighty":-13.330799,"marketCap":2792231115.94},{"date":"2023-05-10","current":-6.689752,"twenty":-57.031699,"median":-34.449204,"eighty":-13.235907,"marketCap":2413896528.97},{"date":"2023-05-19","current":-5.998961,"twenty":-55.865984,"median":-34.307805,"eighty":-12.635355,"marketCap":2164635282.58},{"date":"2023-05-26","current":-6.159383,"twenty":-54.610824,"median":-34.25037,"eighty":-12.304624,"marketCap":2222520838.42},{"date":"2023-06-02","current":-5.896649,"twenty":-53.769073,"median":-34.189583,"eighty":-12.145184,"marketCap":2127717267.98},{"date":"2023-06-09","current":-5.61732,"twenty":-51.214539,"median":-34.098254,"eighty":-11.978924,"marketCap":2026925451.44},{"date":"2023-06-16","current":-6.556151,"twenty":-49.534985,"median":-33.981992,"eighty":-11.716113,"marketCap":2365688683.03},{"date":"2023-06-23","current":-5.188019,"twenty":-48.575977,"median":-33.870975,"eighty":-11.579838,"marketCap":1872018712.18},{"date":"2023-06-30","current":-5.593173,"twenty":-48.355361,"median":-33.644023,"eighty":-11.480192,"marketCap":2018212544.46},{"date":"2023-07-07","current":-5.74663,"twenty":-48.060411,"median":-33.395098,"eighty":-11.347014,"marketCap":2073585481.13},{"date":"2023-07-14","current":-6.162744,"twenty":-47.529274,"median":-33.182708,"eighty":-11.253893,"marketCap":2223733732.38},{"date":"2023-07-21","current":-6.029127,"twenty":-47.271291,"median":-33.060515,"eighty":-11.126783,"marketCap":2175519941.92},{"date":"2023-07-28","current":-6.932729,"twenty":-46.699003,"median":-32.915735,"eighty":-11.040035,"marketCap":2501571410.93},{"date":"2023-08-04","current":-93.761454,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2758743281.53},{"date":"2023-08-11","current":-81.599272,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2400895380.31},{"date":"2023-08-18","current":-77.476828,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2279600704.92},{"date":"2023-08-25","current":-81.532031,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2398916965.04},{"date":"2023-09-01","current":-91.16165,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2682249230.75},{"date":"2023-09-08","current":-82.080837,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2415064449.43},{"date":"2023-09-15","current":-91.04279,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2678752002.43},{"date":"2023-09-22","current":-92.694372,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2727346501.33},{"date":"2023-09-29","current":-98.479468,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2897561388.24},{"date":"2023-10-06","current":-95.557789,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2811596806.75},{"date":"2023-10-13","current":-104.104604,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":3063069736.6},{"date":"2023-10-20","current":-97.193204,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2859715641.7},{"date":"2023-10-27","current":-106.376978,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3129929817.79},{"date":"2023-11-03","current":-113.333081,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3334599265.81},{"date":"2023-11-10","current":-110.227088,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3243211592.97},{"date":"2023-11-17","current":-106.765557,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3141362969.86},{"date":"2023-11-24","current":-109.005881,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3207280038.84},{"date":"2023-12-01","current":-106.403892,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3130721682.86},{"date":"2023-12-08","current":-107.396023,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3159913178.84},{"date":"2023-12-15","current":-114.044196,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3355522389.76},{"date":"2023-12-22","current":-102.844083,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3025981471.63},{"date":"2023-12-29","current":-104.57108,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3076794889.66},{"date":"2024-01-05","current":-97.230433,"twenty":-46.534985,"median":-32.902271,"eighty":-10.987537,"marketCap":2860811039.44},{"date":"2024-01-12","current":-93.788775,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2759547110.77},{"date":"2024-01-19","current":-81.700747,"twenty":-46.617006,"median":-32.897915,"eighty":-10.978873,"marketCap":2403881098.3},{"date":"2024-01-26","current":-75.326321,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2216326338.51},{"date":"2024-02-02","current":-71.131016,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2092887876.59},{"date":"2024-02-09","current":-81.199004,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2389118297.6},{"date":"2024-02-16","current":-84.08213,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2473948515.34},{"date":"2024-02-23","current":-90.549714,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2664244213.15},{"date":"2024-03-01","current":25.78938,"twenty":-46.577409,"median":-32.890218,"eighty":-10.953678,"marketCap":2599053804.56},{"date":"2024-03-08","current":25.462774,"twenty":-45.923863,"median":-32.835083,"eighty":-10.669452,"marketCap":2566138402.88},{"date":"2024-03-15","current":30.565906,"twenty":-45.475099,"median":-32.781518,"eighty":-10.516791,"marketCap":3080431970.72},{"date":"2024-03-22","current":28.107757,"twenty":-45.159274,"median":-32.614784,"eighty":-10.173858,"marketCap":2832699783.36},{"date":"2024-03-28","current":28.634683,"twenty":-44.696755,"median":-32.47029,"eighty":-9.952238,"marketCap":2885803386.55},{"date":"2024-04-05","current":27.994802,"twenty":-44.286361,"median":-32.437839,"eighty":-9.676235,"marketCap":2821316061},{"date":"2024-04-12","current":30.73697,"twenty":-43.790515,"median":-32.383262,"eighty":-9.438819,"marketCap":3097671829.52},{"date":"2024-04-19","current":28.50518,"twenty":-43.289592,"median":-32.314387,"eighty":-9.308641,"marketCap":2872752027.27},{"date":"2024-04-26","current":30.691652,"twenty":-43.110703,"median":-32.225561,"eighty":-9.195832,"marketCap":3093104761.67},{"date":"2024-05-03","current":32.810779,"twenty":-42.925086,"median":-32.090068,"eighty":-9.093044,"marketCap":3306670223.29},{"date":"2024-05-10","current":37.311124,"twenty":-42.754864,"median":-32.013835,"eighty":-9.030734,"marketCap":3760215012.95},{"date":"2024-05-17","current":34.774349,"twenty":-42.519618,"median":-31.926574,"eighty":-8.918389,"marketCap":3504558884.2},{"date":"2024-05-24","current":31.870114,"twenty":-42.406308,"median":-31.731124,"eighty":-8.759961,"marketCap":3211870090.63},{"date":"2024-05-31","current":31.840964,"twenty":-42.321902,"median":-31.616611,"eighty":-8.700526,"marketCap":3208932296.09},{"date":"2024-06-07","current":30.649626,"twenty":-42.069616,"median":-31.52512,"eighty":-8.629123,"marketCap":3088869266.47},{"date":"2024-06-14","current":31.662211,"twenty":-41.839089,"median":-31.349545,"eighty":-8.522865,"marketCap":3190917592.65},{"date":"2024-06-21","current":30.278072,"twenty":-41.728492,"median":-31.238878,"eighty":-8.390524,"marketCap":3051424142.17},{"date":"2024-06-28","current":29.565199,"twenty":-41.372482,"median":-31.203757,"eighty":-8.378139,"marketCap":2979580713.93},{"date":"2024-07-05","current":31.469656,"twenty":-41.171139,"median":-31.162778,"eighty":-8.350361,"marketCap":3171511930.81},{"date":"2024-07-12","current":32.497273,"twenty":-40.923634,"median":-31.106867,"eighty":-8.304192,"marketCap":3275075163.39},{"date":"2024-07-15","current":32.449018,"twenty":-40.883856,"median":-31.083316,"eighty":-8.295844,"marketCap":3270211975.59},{"date":"2024-08-02","current":-73.252444,"twenty":-40.734722,"median":-31.035175,"eighty":-8.234512,"marketCap":3074405105.35},{"date":"2024-08-09","current":-80.817949,"twenty":-40.867508,"median":-31.065396,"eighty":-8.234512,"marketCap":3391929340.66},{"date":"2024-08-16","current":-75.419733,"twenty":-41.029282,"median":-31.08164,"eighty":-8.234512,"marketCap":3165366196.73},{"date":"2024-08-23","current":-70.090937,"twenty":-41.233818,"median":-31.11816,"eighty":-8.234512,"marketCap":2941716616.05},{"date":"2024-08-30","current":-70.200291,"twenty":-41.56077,"median":-31.11816,"eighty":-8.234512,"marketCap":2946306212.08},{"date":"2024-09-06","current":-70.181618,"twenty":-41.811937,"median":-31.11816,"eighty":-8.234512,"marketCap":2945522520.42},{"date":"2024-09-13","current":-69.744859,"twenty":-41.964487,"median":-31.11816,"eighty":-8.234512,"marketCap":2927191709.7},{"date":"2024-09-20","current":-71.615538,"twenty":-42.245335,"median":-31.11816,"eighty":-8.234512,"marketCap":3005704154.39},{"date":"2024-09-27","current":-77.826204,"twenty":-42.356867,"median":-31.178512,"eighty":-8.234512,"marketCap":3266365753.33},{"date":"2024-10-04","current":-82.757332,"twenty":-42.493301,"median":-31.289313,"eighty":-8.234512,"marketCap":3473325219.61},{"date":"2024-10-11","current":-77.57877,"twenty":-42.605,"median":-31.548561,"eighty":-8.234512,"marketCap":3255980971.33},{"date":"2024-10-18","current":-82.642206,"twenty":-42.921343,"median":-31.761378,"eighty":-8.234512,"marketCap":3468493340.62},{"date":"2024-10-25","current":-85.256412,"twenty":-43.016758,"median":-32.001326,"eighty":-8.234512,"marketCap":3578211606.32},{"date":"2024-10-31","current":-74.954799,"twenty":-43.239177,"median":-32.06209,"eighty":-8.234512,"marketCap":3145852920.58},{"date":"2024-11-08","current":-72.692272,"twenty":-43.62805,"median":-32.188654,"eighty":-8.233187,"marketCap":3050894659.02},{"date":"2024-11-15","current":-68.34495,"twenty":-44.002855,"median":-32.188654,"eighty":-8.233187,"marketCap":2868437537.19},{"date":"2024-11-22","current":-71.356956,"twenty":-44.564262,"median":-32.188654,"eighty":-8.233187,"marketCap":2994851469.12},{"date":"2024-11-29","current":-69.444249,"twenty":-44.793919,"median":-32.188654,"eighty":-8.233187,"marketCap":2914575122.66},{"date":"2024-12-06","current":-72.472893,"twenty":-45.245557,"median":-32.188654,"eighty":-8.233187,"marketCap":3041687288.89},{"date":"2024-12-13","current":-63.887587,"twenty":-45.737028,"median":-32.188654,"eighty":-8.233187,"marketCap":2681361994.64},{"date":"2024-12-20","current":-60.618869,"twenty":-46.397964,"median":-32.188654,"eighty":-8.233187,"marketCap":2544173945.26},{"date":"2024-12-27","current":-59.140915,"twenty":-46.839034,"median":-32.188654,"eighty":-8.233187,"marketCap":2482144206.05},{"date":"2025-01-03","current":-61.983512,"twenty":-58.665008,"median":-32.188654,"eighty":-8.233187,"marketCap":2601448012.27},{"date":"2025-01-10","current":-62.344458,"twenty":-60.772335,"median":-32.162743,"eighty":-8.231863,"marketCap":2616596879.5},{"date":"2025-01-17","current":-58.299182,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2446816652.19},{"date":"2025-01-24","current":-55.029289,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2309579252.99},{"date":"2025-01-31","current":-55.715915,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2338396949.9},{"date":"2025-02-07","current":-53.467713,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2244039918.87},{"date":"2025-02-14","current":-55.662649,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2336161367.94},{"date":"2025-02-21","current":-65.870772,"twenty":-61.683916,"median":-32.162743,"eighty":-8.231863,"marketCap":2764596287.73},{"date":"2025-02-28","current":-68.37646,"twenty":-62.164703,"median":-32.162743,"eighty":-8.231863,"marketCap":2869760015.65},{"date":"2025-03-07","current":-68.073966,"twenty":-63.73881,"median":-32.212901,"eighty":-8.230538,"marketCap":2857064342.6},{"date":"2025-03-14","current":-64.060444,"twenty":-64.03835,"median":-32.350855,"eighty":-8.230538,"marketCap":2688616845.96},{"date":"2025-03-21","current":66.690257,"twenty":-64.27493,"median":-32.387163,"eighty":-8.133641,"marketCap":2516156700.16},{"date":"2025-03-28","current":69.598373,"twenty":-64.27493,"median":-32.387163,"eighty":-8.03762,"marketCap":2625877056.17},{"date":"2025-04-04","current":66.45471,"twenty":-64.27493,"median":-32.387163,"eighty":-7.971128,"marketCap":2507269769.7},{"date":"2025-04-11","current":62.287088,"twenty":-64.221309,"median":-32.385213,"eighty":-7.932321,"marketCap":2350029524.92},{"date":"2025-04-17","current":63.677927,"twenty":-64.221309,"median":-32.385213,"eighty":-7.856958,"marketCap":2402504520.39},{"date":"2025-04-25","current":68.867703,"twenty":-64.27493,"median":-32.387163,"eighty":-7.463009,"marketCap":2598309537.11},{"date":"2025-05-02","current":70.00808,"twenty":-64.27493,"median":-32.387163,"eighty":-7.279097,"marketCap":2641334825.25},{"date":"2025-05-09","current":68.704213,"twenty":-64.27493,"median":-32.387163,"eighty":-7.149579,"marketCap":2592141250.63},{"date":"2025-05-16","current":61.687385,"twenty":-64.27493,"median":-32.387163,"eighty":-7.043509,"marketCap":2327403358.61},{"date":"2025-05-23","current":63.281782,"twenty":-64.27493,"median":-32.387163,"eighty":-6.961701,"marketCap":2387558359.74},{"date":"2025-05-30","current":63.269782,"twenty":-64.27493,"median":-32.387163,"eighty":-6.905623,"marketCap":2387105606.22},{"date":"2025-06-06","current":69.305193,"twenty":-64.27493,"median":-32.387163,"eighty":-6.731447,"marketCap":2614815642.59},{"date":"2025-06-13","current":77.57647,"twenty":-64.27493,"median":-32.387163,"eighty":-6.684324,"marketCap":2926882637.05},{"date":"2025-06-20","current":66.613989,"twenty":-64.328552,"median":-32.388787,"eighty":-6.628323,"marketCap":2513279187.31},{"date":"2025-06-27","current":68.13786,"twenty":-64.328552,"median":-32.388787,"eighty":-6.512219,"marketCap":2570773291.5},{"date":"2025-07-03","current":71.210096,"twenty":-64.328552,"median":-32.332621,"eighty":-6.42721,"marketCap":2686685730.87},{"date":"2025-07-11","current":72.572229,"twenty":-64.328552,"median":-32.162743,"eighty":-6.348415,"marketCap":2738077620.44},{"date":"2025-07-18","current":78.450021,"twenty":-64.328552,"median":-32.034774,"eighty":-6.196909,"marketCap":2959840870.68},{"date":"2025-07-25","current":79.176352,"twenty":-64.328552,"median":-31.872185,"eighty":-6.09053,"marketCap":2987244578.9},{"date":"2025-08-01","current":79.150274,"twenty":-64.328552,"median":-31.228469,"eighty":-6.029127,"marketCap":2986260682.88},{"date":"2025-08-08","current":5.542888,"twenty":-64.328552,"median":-31.16064,"eighty":-5.997559,"marketCap":2587874674.36},{"date":"2025-08-15","current":6.05636,"twenty":-64.328552,"median":-31.08164,"eighty":-5.942503,"marketCap":2827605584.52},{"date":"2025-08-22","current":5.906994,"twenty":-64.328552,"median":-30.975476,"eighty":-5.89292,"marketCap":2757868947.74},{"date":"2025-08-29","current":5.520039,"twenty":-64.328552,"median":-30.692254,"eighty":-5.837513,"marketCap":2577207033.23},{"date":"2025-09-05","current":5.773462,"twenty":-64.348416,"median":-30.330097,"eighty":-5.808798,"marketCap":2695525455.08},{"date":"2025-09-12","current":6.495449,"twenty":-64.328552,"median":-30.080885,"eighty":-5.771921,"marketCap":3032608180.86},{"date":"2025-09-19","current":6.361988,"twenty":-64.328552,"median":-29.783366,"eighty":-5.714542,"marketCap":2970297324.15},{"date":"2025-09-26","current":5.650636,"twenty":-64.328552,"median":-29.518985,"eighty":-5.625246,"marketCap":2638180258.96},{"date":"2025-10-03","current":5.974641,"twenty":-64.328552,"median":-29.153616,"eighty":-5.593173,"marketCap":2789452419.21},{"date":"2025-10-10","current":5.77709,"twenty":-64.328552,"median":-28.940995,"eighty":-5.517888,"marketCap":2697219539.83},{"date":"2025-10-17","current":5.438003,"twenty":-64.328552,"median":-27.613233,"eighty":-5.358513,"marketCap":2538905465.8},{"date":"2025-10-24","current":5.566179,"twenty":-64.328552,"median":-26.616683,"eighty":-5.24792,"marketCap":2598748900.26},{"date":"2025-10-31","current":5.323193,"twenty":-64.328552,"median":-26.259383,"eighty":5.316035,"marketCap":2485303049.86},{"date":"2025-11-07","current":5.692673,"twenty":-64.328552,"median":-25.831006,"eighty":5.422523,"marketCap":2657806660.11},{"date":"2025-11-14","current":5.538607,"twenty":-64.328552,"median":-25.574426,"eighty":5.520039,"marketCap":2585875851.6},{"date":"2025-11-21","current":5.228746,"twenty":-64.328552,"median":-25.210285,"eighty":5.538607,"marketCap":2441207293.13},{"date":"2025-11-28","current":5.415727,"twenty":-64.328552,"median":-23.125526,"eighty":5.538607,"marketCap":2528505283.04},{"date":"2025-12-05","current":5.234536,"twenty":-64.328552,"median":-17.960601,"eighty":5.538607,"marketCap":2443910845.71},{"date":"2025-12-12","current":5.038573,"twenty":-64.328552,"median":-17.484256,"eighty":5.538607,"marketCap":2352418929.73},{"date":"2025-12-19","current":4.906191,"twenty":-64.328552,"median":-16.980776,"eighty":5.538607,"marketCap":2290612111.23},{"date":"2025-12-26","current":4.891268,"twenty":-64.328552,"median":-16.438933,"eighty":5.538607,"marketCap":2283644877.95},{"date":"2026-01-02","current":5.059143,"twenty":-64.328552,"median":-15.7025,"eighty":5.538607,"marketCap":2362022580.17},{"date":"2026-01-09","current":5.365899,"twenty":-64.328552,"median":-15.255817,"eighty":5.538607,"marketCap":2505241950.3},{"date":"2026-01-16","current":5.891548,"twenty":-64.328552,"median":-14.764247,"eighty":5.547002,"marketCap":2750658052.81},{"date":"2026-01-23","current":5.589246,"twenty":-64.328552,"median":-13.552429,"eighty":5.564767,"marketCap":2609518309.27},{"date":"2026-01-30","current":5.579629,"twenty":-64.328552,"median":-13.378369,"eighty":5.577919,"marketCap":2605028588.75},{"date":"2026-02-06","current":5.333987,"twenty":-64.328552,"median":-13.08706,"eighty":5.577919,"marketCap":2490342690.22},{"date":"2026-02-13","current":5.391763,"twenty":-64.328552,"median":-12.446216,"eighty":5.577919,"marketCap":2517316830.13},{"date":"2026-02-20","current":5.446666,"twenty":-64.328552,"median":-12.223865,"eighty":5.577919,"marketCap":2542950715.44},{"date":"2026-02-25","current":5.482944,"twenty":-64.328552,"median":-12.132965,"eighty":5.577919,"marketCap":2559888113.93}],"updateTime":1772110763190},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HCM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602795543","title":"Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2602795543","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602795543?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965400,"startTime":"0","endTime":"0","summary":"Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 withLonger-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK-1 Trial of Adults with MYBPC3-Associated HCM Expects to Repor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/09/3216081/0/en/Tenaya-Therapeutics-Announces-2026-Strategic-Priorities-and-Anticipated-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","TNYA","BK4585","BK4588","BK4531","BK4539","HCM"],"gpt_icon":0},{"id":"1189842852","title":"Multiple Positive Catalysts Drive Five-Day Rally, Is HUTCHMED (00013) Turning Around After Missing the Bull Run?","url":"https://stock-news.laohu8.com/highlight/detail?id=1189842852","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189842852?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:53","pubTimestamp":1767959587,"startTime":"0","endTime":"0","summary":"In 2025, despite a significant second-half pullback, the Hang Seng Healthcare Index still managed to close the year with over a 50% gain. In stark contrast, HUTCHMED (00013), an innovative...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","00013","BK1587","BK1191","BK4588","BK4531","BK4585","BK1588","HCM"],"gpt_icon":0},{"id":"2601871311","title":"Hutchmed Says Autoimmune Disorder Trial in China Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2601871311","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601871311?lang=en_us&edition=fundamental","pubTime":"2026-01-07 18:11","pubTimestamp":1767780705,"startTime":"0","endTime":"0","summary":"Hutchmed  said late Tuesday a phase III registration part of a clinical trial of sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia in China met its primary endpoint.The study showed a durable hemoglobin response rate within weeks five to 24 of treatment, the company said.Autoimmune hemolytic anemia is an autoimmune disorder characterized by the destruction of red blood cells.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","HCM","BK4531","BK4585","BK4007"],"gpt_icon":0},{"id":"1176779538","title":"HUTCHMED (00013) Announces Positive Top-Line Results from Phase III Stage of ESLIM-02 Study of Sovleplenib in Warm Antibody Autoimmune Hemolytic Anemia in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1176779538","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176779538?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:08","pubTimestamp":1767744509,"startTime":"0","endTime":"0","summary":"The Phase III registration stage of the ESLIM-02 study evaluating the novel spleen tyrosine kinase (Syk) inhibitor sovleplenib in adult patients with warm antibody autoimmune hemolytic anemia (wAIHA)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK4531","BK4588","HCM","BK4585","BK4134","III","00013","BK1191","BK4007","BK1587"],"gpt_icon":0},{"id":"2601449388","title":"A Look At Edgewise Therapeutics (EWTX) Valuation After Positive CIRRUS HCM Phase 2 Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2601449388","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601449388?lang=en_us&edition=fundamental","pubTime":"2026-01-07 06:18","pubTimestamp":1767737883,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) recently reported positive updates from its Phase 2 CIRRUS HCM trial for EDG-7500, a cardiac sarcomere modulator targeting hypertrophic cardiomyopathy, drawing fresh attention to the company’s broader pipeline and stock.\nSee our latest analysis for Edgewise Therapeutics.\nThe CIRRUS HCM update has arrived after a strong 90 day share price return of 53.55%, although the 1 year total shareholder return of a 7.20% decline and very large 3 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ewtx/edgewise-therapeutics/news/a-look-at-edgewise-therapeutics-ewtx-valuation-after-positiv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ewtx/edgewise-therapeutics/news/a-look-at-edgewise-therapeutics-ewtx-valuation-after-positiv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HCM","EWTX","02507","BK4588","BK1211","BK4007","BK4585","BK4539","BK4531"],"gpt_icon":0},{"id":"2601002283","title":"Malaysian Shares Rebound Mirroring Regional Gains; Vetece's Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002283","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601002283?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:41","pubTimestamp":1767606115,"startTime":"0","endTime":"0","summary":"Malaysian stocks rose slightly on Monday, snapping a two-day losing streak, and in line with regional gains.The FTSE Bursa Malaysia KLCI gained 10.56 points to end 0.6% higher at 1,680.32. The day range was between 1,669.08 and 1,681.94.In corporate news, shares of Vetece  gained over 4% on Monday's close after its unit Vision Technology Consulting signed a contract with a leading Malaysian utility company to provide an international Human Capital Management  Cloud software subscription valued at about 12.6 million ringgit.Whereas, shares of Glomac  slid over 1% on close after its unit Glomac Al Batha agreed to sell two leasehold plots in Puchong, Malaysia, for 97.3 million to Sunway Kiara.Meanwhile, Guan Huat Seng  is seeking to raise about 30 million ringgit from its initial public offering on the ACE Market of Bursa Malaysia. The IPO entails a public issue of 120 million shares at a tentative price of 0.25 ringgit each, as well as an offer for sale of 21 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","HCM","BK4007","BK4531"],"gpt_icon":0},{"id":"2601526002","title":"Hutchmed Starts Phase III Trial of Pancreatic Cancer Treatment Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2601526002","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601526002?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:31","pubTimestamp":1767605469,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) said Sunday it started a phase III of its trial to evaluate the efficacy of the combination of surufatinib, camrelizumab, nab-paclitaxel and gemcitabine to treat adults with metastatic ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCM","BK4588","BK4531","BK4007","BK4585","BK4134","III"],"gpt_icon":0},{"id":"2601008906","title":"Vetece Unit Wins About MYR13 Million HCM Cloud Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2601008906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601008906?lang=en_us&edition=fundamental","pubTime":"2026-01-05 14:37","pubTimestamp":1767595052,"startTime":"0","endTime":"0","summary":"Vetece  unit Vision Technology Consulting signed a contract with a leading Malaysian utility company to provide an international Human Capital Management  Cloud software subscription valued at about 12.6 million ringgit, according to a Friday Malaysian bourse filing.Shares of the enterprise IT services provider slid 2% in Monday's midday trade.The project is expected to be delivered over the financial years ending Aug. 31, 2026 to Aug. 31, 2029.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4531","HCM","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"1168150943","title":"HUTCHMED (00013) Initiates Phase III Stage of Ongoing Study of Surufatinib Combined with Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1168150943","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168150943?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:12","pubTimestamp":1767571948,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced today the initiation of the Phase III portion of its China-based Phase II/III study evaluating surufatinib in combination with camrelizumab, nab-paclitaxel, and gemcitabine...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK4585","BK4588","BK4134","BK1191","BK1587","BK4007","00013","BK4531","III","HCM"],"gpt_icon":0},{"id":"2595079982","title":"Hutchmed Says New Application for Gastric Cancer Treatment Gets Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2595079982","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595079982?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:49","pubTimestamp":1767091750,"startTime":"0","endTime":"0","summary":"Hutchmed  said Tuesday the China National Medical Products Administration has granted priority review to the company's new drug application for savolitinib to treat locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients.The specific indication is for patients with MET amplification who have failed at least two previous systemic treatments, according to the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCM","BK4585","BK4588","BK4531","BK4007"],"gpt_icon":0},{"id":"1139978406","title":"HUTCHMED (00013) Announces NDA Acceptance and Priority Review Status in China for Savolitinib in MET-Amplified Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1139978406","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139978406?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:10","pubTimestamp":1767089426,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced that the New Drug Application (NDA) for savolitinib has been accepted by the China National Medical Products Administration (NMPA) and granted priority review. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK4162","BK1587","LU1496350502.SGD","LU1989771016.USD","HCM","BK4585","LU1989772923.USD","BK4588","BK1191","LU1989772840.SGD","MET","00013","LU1291159041.SGD","BK1588","BK4007"],"gpt_icon":0},{"id":"2595786132","title":"Hutchmed Says Chinese Regulator Granted Priority Review Status to New Drug Application for Fanregratinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2595786132","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595786132?lang=en_us&edition=fundamental","pubTime":"2025-12-29 17:45","pubTimestamp":1767001518,"startTime":"0","endTime":"0","summary":"Hutchmed  said Monday that the China National Medical Products Administration accepted the new drug application for fanregratinib as a potential treatment for adult patients with advanced, metastatic or unresectable intrahepatic cholangiocarcinoma and gave the application priority review status.The company said the application is backed by data from a phase 2 study in China, which met its primary endpoint of objective response rate.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","BK4585","BK4531","HCM"],"gpt_icon":0},{"id":"1190145372","title":"HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1190145372","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190145372?lang=en_us&edition=fundamental","pubTime":"2025-12-29 16:41","pubTimestamp":1766997665,"startTime":"0","endTime":"0","summary":"tags.  HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review HUTCHMED (00013) announced that the New...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1191","BK4585","BK1587","BK4531","BK1588","BK4007","HCM","00013"],"gpt_icon":0},{"id":"2592050197","title":"Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2592050197","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592050197?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:00","pubTimestamp":1766178000,"startTime":"0","endTime":"0","summary":"MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM  MYQORZO is Company’s First FDA-Appro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/19/3208724/35409/en/Cytokinetics-Announces-FDA-Approval-of-MYQORZO-aficamten-for-the-Treatment-of-Adults-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-to-Improve-Functional-Capacity-and-Sym.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HCMA","HCM","BK4531","BK4588","BK4505","BK4139","BK4585","CYTK"],"gpt_icon":0},{"id":"2592997151","title":"Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China  for Patients with Obstructive Hypertrophic Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592997151","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592997151?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:30","pubTimestamp":1765974600,"startTime":"0","endTime":"0","summary":"Approval Triggers Milestone Payment of $7.5 Million from Sanofi;Cytokinetics Eligible to Receive Additional Milestone Payments and Royalties on Net Sales in Greater China SOUTH SAN FRANCISCO, Calif., ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206907/35409/en/Cytokinetics-Announces-NMPA-Approval-of-MYQORZO-aficamten-in-China-for-Patients-with-Obstructive-Hypertrophic-Cardiomyopathy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4588","BK4007","BK4531","BK4087","CYTK","HCM","BK4585","BK4139","CHMP","BK4156"],"gpt_icon":0},{"id":"2592912809","title":"Hutchmed Begins Phase 1 Study of HMPL-A251 Monotherapy to Treat Patients With Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2592912809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592912809?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:20","pubTimestamp":1765970429,"startTime":"0","endTime":"0","summary":"Hutchmed  said Wednesday it has initiated a global phase 1 clinical development program for its HMPL-A251 monotherapy candidate derived from the company's ATTC platform, in patients with solid tumors.The first patient was dosed on Tuesday in China, the company said.Hutchmed said the primary outcome measures of the study are to evaluate the safety and tolerability of HMPL-A251 and to determine the maximum tolerated dose and recommended dose for expansion in the first phase of the trial. In the following phases, further safety evaluation and preliminary efficacy at recommended doses will be studied.Secondary outcome measures of the study include preliminary antitumor activity, pharmacokinetic profile, and the immunogenicity of HMPL-A251, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4531","HCM","BK4588","BK4007"],"gpt_icon":0},{"id":"1168135280","title":"HUTCHMED (00013) Initiates Global Clinical Development of ATTC Candidate HMPL-A251 for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1168135280","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168135280?lang=en_us&edition=fundamental","pubTime":"2025-12-17 08:18","pubTimestamp":1765930716,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced the initiation of a global Phase I clinical development program for HMPL-A251. HMPL-A251 is a first-in-class PI3K/PIKK-HER2 antibody-targeted conjugate (ATTC), composed of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","00013","BK1191","BK1588","BK4585","BK4588","BK1587","BK4531","HCM"],"gpt_icon":0},{"id":"2592930382","title":"Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2592930382","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592930382?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:00","pubTimestamp":1765918800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  16, 2025  (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 15, 2025 it granted stock options to purchase an aggregate o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206592/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU2417539215.USD","LU0098860793.USD","HCM","LU0072461881.USD","IE00BSNM7G36.USD","LU0477156953.USD","LU1162221912.USD","BK4588","LU2236285917.USD","LU0106831901.USD","CYTK","LU0130517989.USD","LU1201861249.SGD","LU0128525689.USD","LU0648001328.SGD","LU0320765646.SGD","BK4139","LU1267930227.SGD","LU1791807156.HKD","LU2125154935.USD","LU0170899867.USD","LU1244550494.USD","LU2462157665.USD","BK4007","LU0130102774.USD","LU0310800965.SGD","LU1244550577.SGD","LU0980610538.SGD","LU1366192091.USD","LU0162691827.USD","BK4534","BK4559","LU2125154778.USD","BK4585","LU2360032135.SGD","LU2456880835.USD","LU1668664300.SGD","LU0052756011.USD","LU1244550221.USD","BK4531","BK4504","BK4207","BK4566"],"gpt_icon":0},{"id":"2591684828","title":"Press Release: UKG Agrees to Acquire Inova Payroll","url":"https://stock-news.laohu8.com/highlight/detail?id=2591684828","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591684828?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:51","pubTimestamp":1765576260,"startTime":"0","endTime":"0","summary":"Acquisition Strengthens Ability to Directly Support Small and Mid-Sized Businesses with Expanded Service Offerings. UKG Inc., a leading global AI platform unifying HR, pay, and workforce management, has entered into a definitive agreement to acquire Inova Payroll, a U.S.-based human capital management  and payroll services provider for small and mid-sized businesses . The acquisition, which is subject to customary closing conditions, will enable UKG to directly provide the SMB market segment with innovative outsourced HR support and full benefits brokerage services.Based in Nashville, Tennessee, Inova serves more than 4,000 businesses. As the largest reseller of the UKG Ready suite nationwide, Inova enhances HR operations through outsourced expertise and robust benefits support, helping employers more easily manage everyday HR tasks and compliance to better serve employees. Targeted third-party technology integrations help streamline essential processes and reduce manual effort.Inova h","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4585","HCM","BK4531","R","BK4007","BK4588"],"gpt_icon":0},{"id":"2590454151","title":"Tenaya Therapeutics Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590454151","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590454151?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:02","pubTimestamp":1765486920,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  11, 2025  (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204290/0/en/Tenaya-Therapeutics-Announces-Proposed-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","TNYA","BK4588","BK4539","BK4531","BK4585","HCM"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":99,"code":"91000000","status":"200"}]}}